Interferences

For decades, Sterne Kessler has successfully handled dozens of interferences, with experience that runs the gamut from pre-declaration activities to successful appeals to the Federal Circuit.

Sterne Kessler has represented U.S. and foreign clients in two-party and multiparty interferences. We have successfully represented patentees in defending against post-issuance interferences and also have successfully represented applicants against both patentees and other applicants.

Our seasoned, efficient, and knowledgeable team has experience across technologies, including biotechnology, electronics, and manufacturing.  Legal representation in this complex area of patent law requires a keen understanding of the technology, the substantive law of interferences and—quite critically—interference procedure. This understanding encompasses all phases of the practice, including the copying of claims, motions, count formation, testimony period, depositions, and corroborated proofs, as well as final hearings before the Board and appeals to the Federal Circuit.

Pre-Interference Procedures

Our practice includes counseling clients on various issues that precede the declaration of an interference, including

  • Preparing and filing requests for interference
  • Filing reissue applications of our clients’ issued U.S. patents
  • Provoking interferences with the issued patents of opponents during the reissue process
  • Prosecuting applications that present interference issues before the Examiner while successfully avoiding an interference upon patent issuance
  • Preparing our clients to be favorably positioned by watching for the publication of patent applications of competitors

Settlements

In our experience, most interferences settle rather than get to Final Hearing—settlement is certainly the most expedient means to finalize what has become in recent years a long, drawn-out, and resource-intensive procedure. We leverage our experience to efficiently resolve these disputes, including negotiating settlement agreements, licensing agreements that normally accompany settlements, and mutual exchanges of proofs and mutual decisions on allocation of priorities.

Derivation Proceedings

Sterne Kessler has a rare level of experience with derivations, a nuanced and infrequently-occurring inventorship dispute resolution proceeding.

Derivation proceedings were introduced along with inter partes review (IPR) with the America Invents Act (AIA) over a decade ago. As proceedings that deal with inventorship disputes, derivations are the post-AIA successors to interference proceedings. With that in mind, we leverage experience in dozens of interference representations to bolster our derivation strategies. In addition, our leadership in other AIA-proceedings, such as IPRs, helps to inform our participation in these proceedings.

Sterne Kessler has experience in several public derivations, and has gained experience in a variety of other matters that are not publicly available. In particular, we represented adidas as the respondent in a trio of derivations, securing an institution denial in each proceeding.

Related Resources

Firm Announcements

Sterne Kessler and Patterson IP Law Team Up to Secure $12.9M Wirtgen Win Over Caterpillar

Sterne, Kessler, Goldstein & Fox February 27, 2024

In the News

Caterpillar Owes Deere $13 Million in Road-Milling Patent Trial

Bloomberg Law February 27, 2024

In the News

Caterpillar to Pay Wirtgen $12.9M in Damages After Patent Battle

Construction Briefing February 26, 2024

Bylined Articles

Federal Circuit Cases Exploring a Year of Rules, Rulemaking, and Rule Enforcement at the PTAB

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

The Changing Contours of IPR Estoppel Law

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

Reexamination Statistics and the Federal Circuit’s SNQ Clarification/Expansion

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

Key 2023 PTAB Statistics

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

The Staying Power of Fintiv: The Effect of Parallel Litigation at the PTAB in 2023

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

Watch Your Step – Discretionary Denial Under 325(d) Is Alive and Kicking

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

2023 Changes in Director Review

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

2023 PTAB Case Highlights

Sterne, Kessler, Goldstein & Fox February 8, 2024

Bylined Articles

2023 PTAB Year in Review: Editors’ Introduction

Sterne, Kessler, Goldstein & Fox February 8, 2024

Reports

2023 PTAB Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox February 8, 2024

Press Release

Award-Winning PTAB Team Publishes 2023 PTAB Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox February 8, 2024

In the News

PTAB Filings Drop Alongside Declining Patent Litigation

Law360 February 7, 2024

Bylined Articles

PTAB: Design Patents for GUI Interface Cancelled in AIA Proceedings

Sterne, Kessler, Goldstein & Fox January 31, 2024

Bylined Articles

An Introduction from the Editor – 2023 Design Patents Year in Review: Analysis and Trends

Sterne, Kessler, Goldstein & Fox January 31, 2024

Reports

2023 Design Patents Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox January 31, 2024

Press Release

Sterne Kessler Publishes 2023 Design Patents Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox January 31, 2024

In the News

Petition Watch: Patent Obviousness, ADA Trials, Spoofing

Law360 January 25, 2024

Podcast Recording & Transcript

From PhD to Partner: Biotechnology and Patent Law w/ Eldora Ellison

February 15, 2023

In the News

Patent Cases To Watch in 2023

Law360 January 2, 2023

In the News

Korean Co. Can’t Be First To Invent CRISPR, PTAB Told

Law360 September 12, 2022

In the News

These IP Boutique Firms Are Dominating PTAB Work

Law360 May 19, 2022

In the News

PTAB Judge Grills UC on Evidence It Invented CRISPR First

Law360 February 4, 2022

Speaking Engagement

Which Way Now with the U.S. Patent Office Policies?

November 5, 2021 9:30 AM - 10:15 AM PST

Speaking Engagement

Keeping Up With Developments at the PTAB

November 3, 2021 10:05 AM - 11:05 AM PST

In the News

Uptick in 2020 PTAB Cases May Signal New Normal

Law360 March 10, 2021

Speaking Engagement

LSPN Connect Perspectives: An Interview with Eldora Ellison

October 27, 2020 12:00 PM - 1:00 PM PST

Press Release

Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology

Sterne, Kessler, Goldstein & Fox P.L.L.C. October 8, 2020

In the News

Top 6 Patent Rulings Of 2020: A Midyear Report

Law360 June 29, 2020

In the News

UC now holds largest CRISPR-Cas9 patent portfolio

University of California, Berkeley October 1, 2019

In the News

University of California awarded 15th U.S. CRISPR-Cas9 patent

University of California, Berkeley September 24, 2019

In the News

CRISPR portfolio now at 14 and counting

University of California, Berkeley September 17, 2019

In the News

UC awarded 12th patent for CRISPR-Cas9 gene-editing technology

The Daily Californian September 8, 2019

In the News

Twelfth CRISPR patent awarded to UC team

University of California, Berkeley September 3, 2019

In the News

Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U. Vienna, Charpentier

Genetic Engineering & Biotechnology News August 23, 2019

In the News

University of California awarded new U.S. CRISPR-Cas9 patent

University of California, Berkeley August 20, 2019

In the News

Newly granted CRISPR patents boost UC’s U.S. portfolio to 10

University of California, Berkeley July 23, 2019

In the News

CRISPR-Cas 9 patent granted to University of California

Biopharmapress July 17, 2019

In the News

Eighth CRISPR patent issued by U.S.; seven more soon to come

University of California, Berkeley July 16, 2019

In the News

Seventh CRISPR Patent Awarded to Doudna/Charpentier Team

University of California, Berkeley July 2, 2019

In the News

Interference Declared over CRISPR-Cas9 for Eukaryotic Cells, Reigniting Patent War

Genetic Engineering & Biotechnology News June 28, 2019

In the News

New Battle in CRISPR Patent War Adds To The Uncertainty Surrounding The Technology

Intellectual Asset Management June 28, 2019

In the News

USPTO Revives Fight Over CRISPR Patents

Life Sciences Intellectual Property Review June 27, 2019

In the News

Dispute Over Patent Rights to CRISPR-Cas9 Renewed By Patent Office

Drug Target Review June 27, 2019

In the News

PTAB launches CRISPR patent interference

Intellectual Property Magazine June 27, 2019

In the News

USPTO Reverses Decision Regarding Interfering CRISPR Patents

Pharmaceutical Technology June 26, 2019

In the News

Patent Office Renews Dispute Over Patent Rights to CRISPR-Cas9

University of California, Berkeley June 25, 2019

In the News

USPTO Launches New Round In CRISPR Patent War

Law360 June 25, 2019

In the News

Gene-Editing Battle Heats Up as U.S. Probes Who Invented First

Bloomberg Law June 25, 2019

In the News

University Of California Gets 5th CRISPR Patent

Law360 May 29, 2019

In the News

USPTO Issues 5th U.S. CRISPR-Cas9-Related Patent to University of California

University of California Office of the President May 28, 2019

Press Release

MIP Distinguishes Three Sterne Kessler Directors Among Top 250 Women in IP

Sterne, Kessler, Goldstein & Fox PLLC May 23, 2019

In the News

UC Berkeley Receives its 4th CRISPR Patent, Expects 3 More After

The Daily Californian May 1, 2019

In the News

UC Receives Fourth CRISPR Patent; Three More on the Way

University of California, Berkeley April 29, 2019

In the News

University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent

Genetic Engineering & Biotechnology News April 29, 2019

Press Release

Sterne Kessler Directors Recognized Among the World’s Leading IP Practitioners

World Intellectual Property Review February 20, 2019

In the News

U.S. Patent Office Indicates it will Issue Third CRISPR Patent to UC

University of California, Berkeley February 8, 2019

In the News

Fight Over Who Invented CRISPR Isn’t Done With Berkeley Patent

Bloomberg Law February 8, 2019

In the News

Golf Club Makers Settle Sprawling 23-Patent Suit

Law360 February 4, 2019

Speaking Engagement

Microbiome R&D and Business Collaboration Forum: USA

October 29, 2018 12:00 AM - 11:59 PM PST

Press Release

IP Powerhouse Sterne, Kessler, Goldstein & Fox Celebrates 40th Anniversary

Sterne, Kessler, Goldstein & Fox October 2, 2018

In the News

USPTO Patent-Eligibility Revamp May Face Court Skepticism

Law360 September 25, 2018

In the News

Are PTAB Appointments Unconstitutional? A Closer Look

Law360 September 5, 2018

In the News

PTAB Agrees To Review Golf Club Patent Challenges

Law360 August 31, 2018

Bylined Articles

The impact of Oil States and SAS on the post-grant landscape

The Patent Lawyer July 31, 2018

Press Release

Sterne Kessler Directors Recognized Among the World’s Leading IP Practitioners

World Intellectual Property Review February 20, 2018